Page last updated: 2024-10-31

miconazole and Dysmyelopoietic Syndromes

miconazole has been researched along with Dysmyelopoietic Syndromes in 1 studies

Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamei, H1
Toki, H1
Fugii, M1
Okabe, K1
Segawa, Y1

Other Studies

1 other study available for miconazole and Dysmyelopoietic Syndromes

ArticleYear
[A case of septicemia caused by Trichosporon beigelii (cutaneum) in a patient with myelodysplastic syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:7

    Topics: Amphotericin B; Female; Humans; Miconazole; Middle Aged; Mycoses; Myelodysplastic Syndromes; Sepsis;

1989